Claims for Patent: 5,641,790

Summary for Patent: 5,641,790

Title:	Methods of use for inhibiting bone loss and lowering serum cholesterol
Abstract:	A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Inventor(s):	Draper; Michael W. (Carmel, IN)
Assignee:	Eli Lilly and Company (Indianapolis, IN)
Application Number:	08/422,417
Patent Claims:	1. A pharmacuetical formulation in dosage unit form comprising per dosage unit, an amount within the range of about 55 to about 150 mg of a compound of formula I ##STR3## or a pharmaceutically acceptable salt or solvate thereof. 2. A pharmaceutical formulation of claim 1 in a form adapted for administration to inhibit bone loss. 3. A pharmaceutical formulation of claim 1 in a form adapted for administration to lower serum cholesterol or. 4. A pharmaceutical formulation of claim 1 in a form adapted for oral administration. 5. A pharmaceutical formulation of claim 1 in the form of a capsule. 6. A pharmaceutical formulation of claim 1 in the form of a tablet. 7. A pharmaceutical formulation of claim 1 in the form of a suspension. 8. A pharmaceutical formulation of claim 1 wherein the dosage unit is 60 mg. 9. A pharmaceutical formulation of claim 1 wherein the dosage unit is 75 mg. 10. A pharmaceutical formulation of claim 1 wherein the dosage unit is 100 mg. 11. A pharmaceutical formulation of claim 1 wherein the dosage unit is 125 mg. 12. A pharmaceutical formulation of claim 1 wherein the dosage unit is 150 mg. 13. A pharmaceutical formulation in dosage unit form comprising, per dosage unit, an amount within the range of about 60 to about 100 mg of a compound of formula I ##STR4## or a pharmaceutically acceptable salt or solvate thereof.